ENaC Channel: Targeting A Promising Drug Pathway for Disease Treatment

Target Name: Epithelial Sodium Channel (ENaC)

NCBI ID: P6278

Epithelial Sodium Channel (ENaC)

Other Name(s): Amiloride sensitive sodium channel | ENaC | Epithelial sodium channel | Sodium Channel, Nonvoltage-Gated 1 | Sodium channel non-neuronal 1

ENaC Channel: Targeting A Promising Drug Pathway for Disease Treatment

Epithelial sodium channels (ENaCs) are a family of ion channels that are responsible for the regulation of sodium and water transport in the epithelial membrane of the body. They are essential for maintaining the integrity of various physiological processes, including cell signaling, nerve function, and blood pressure. ENaCs have been implicated in a wide range of diseases, including hypertension, diabetes, and various cancers. As a result, they have emerged as a promising drug target for researchers to develop new treatments for these diseases.

ENaCs are a type of ion channel that is characterized by the presence of a protein called the epithelial sodium channel (ENaC). ENaC is a transmembrane protein that is composed of two main subunits: the N-terminus alpha subunit and the C-terminus beta subunit. The N-terminus alpha subunit is responsible for the channel's conductivity, while the C-terminus beta subunit is responsible for the channel's stability.

ENaC is expressed in various tissues throughout the body, including the brain, heart, kidneys, and intestine. It is responsible for regulating the transport of sodium and water across the membrane of these tissues, which is critical for maintaining the proper functioning of these organs. ENaC is also involved in several signaling pathways that are important for various physiological processes, including cell signaling, nerve function, and blood pressure.

One of the key functions of ENaC is its role in maintaining the integrity of the epithelial membrane. ENaC helps to regulate the movement of water and sodium into and out of cells, which is critical for maintaining the proper volume of these molecules in the cell. This is important for maintaining the proper functioning of various organs, including the brain, heart, and kidneys. ENaC also helps to regulate the production of intracellular water, which is critical for maintaining the proper hydration of these organs.

ENaC is also involved in several signaling pathways that are important for various physiological processes. For example, ENaC is involved in the regulation of pain perception, which is critical for maintaining the proper functioning of the nervous system. ENaC is also involved in the regulation of inflammation, which is important for maintaining the proper functioning of the immune system.

Despite the importance of ENaC in various physiological processes, it is often targeted by drugs that are designed to inhibit its function. This is because ENaC is a key player in several diseases, including hypertension, diabetes, and various cancers. As a result, researchers are actively working to develop new treatments for these diseases that target ENaC.

One approach to targeting ENaC is through the use of small molecules that are known to be inhibitors of ENaC. These molecules can be used to treat a wide range of diseases, including hypertension, diabetes, and various cancers. For example, a commonly used drug for hypertension is amiloride, which is known to be an inhibitor of ENaC. Amiloride works by blocking the function of ENaC, which can lead to the regulation of sodium and water transport in the body.

While amiloride is an effective treatment for hypertension, it is not without potential side effects. As with many drugs, amiloride can cause unintended side effects, such as nausea, vomiting, and a decrease in blood pressure. In addition, amiloride can cause a condition called hyperkalemia, which is characterized by an increase in the levels of potassium in the body. This can be dangerous, as high levels of potassium can cause muscle weakness, cardiac arrhythmias, and other serious health problems.

To address these potential side effects, researchers are working to develop new treatments for ENaC that are less invasive and more effective. One approach is to develop drugs that are designed to specifically target ENaC without causing unintended side effects. This is an important goal, as many diseases are treated with drugs that can cause unintended side effects, which can

Protein Name: Epithelial Sodium Channel (ENaC)

The "Epithelial Sodium Channel (ENaC) Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Epithelial Sodium Channel (ENaC) comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets